Today, Ultragenyx Pharmaceuticals shared a press release announcing a “Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program.”
Read the full press release here.
Tune into the LIVESTREAM updates at the ASF Family Conference on Wednesday, July 24th at 3:10pm ET. To access the link, click here and select Day 2.